I'm retired metoprolol succinate recall 2018 PARIS, Sept 25 (Reuters) - A new cholesterol-lowering drugfrom Sanofi and Regeneron has the potentialto become a $3-billion-dollar-plus blockbuster, according toanalysts awaiting imminent late-stage trial results.
